Riding the pepTIDE — The Daily Wire on Therapeutic Peptides

An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.

Topic Sections

  • Top Shots — The most significant peptide and longevity stories ranked by overall editorial score
  • Research Signals — High-credibility scientific findings from journals, preprints, and clinical sources
  • Healing & Recovery — Tissue repair, injury recovery, and gut healing peptides including BPC-157 and TB-500
  • Growth Hormone Wire — Growth hormone secretagogues, peptide stacks, and GH axis research including Ipamorelin, CJC-1295, and MK-677
  • Metabolic & GLP-1 — Metabolic health, insulin sensitivity, and GLP-1 receptor agonist research including semaglutide and tirzepatide
  • Cognitive / Nootropic — Peptides targeting brain function, memory, neuroprotection, and cognitive enhancement
  • Skin & Cosmetic — Skin repair, anti-aging, collagen synthesis, and cosmetic peptide research including GHK-Cu and matrixyl
  • Reddit Finds — Community-sourced discussions, self-experimentation reports, and protocol threads from peptide communities
  • Contrarian Takes — Alternative viewpoints, dissenting research, and perspectives that challenge mainstream peptide narratives
  • Skeptic's Corner — Hype debunking, low-evidence alerts, and critical analysis of overstated peptide claims

Browse by Filter

  • Newest — Latest peptide and longevity stories
  • Most Credible — Highest credibility-scored stories
  • Most Edgy — High-novelty, unconventional findings
  • Most Discussed — Trending community discussions
  • Most Actionable — Direct applicability to daily health protocols
  • Lowest Risk — Stories with strong evidence, low hype
  • Research Only — Peer-reviewed and preprint studies
  • Reddit Only — Community discussion and anecdote
  • GLP-1 / Metabolic — Semaglutide, tirzepatide, and metabolic peptides
  • Healing / Recovery — BPC-157, TB-500, and repair protocols

More

  • About Riding the pepTIDE
  • Health Disclaimer
  • Submit a Source
  • Contact

Wegovy's 25mg Tablet Cuts Appetite Too Much — Try Every-Other-Day Dosing?

Someone on an online forum says they’re on the 25 mg Wegovy tablet and the appetite suppression is stronger than they want. They’ve been titrating up over several months and now find it hard to eat enough before runs and workouts. They’re asking whether taking the pill every other day instead of daily might help. Wegovy is the brand name for semaglutide in a tablet form used for weight management. Semaglutide is a drug that acts like a natural gut hormone that tells your brain you’re full and slows stomach emptying, so you feel less hungry and eat less. It was developed as a once-daily tablet (or once-weekly injection in other versions) to lower appetite and help people lose weight when used with diet and exercise. The post is a personal report, not a clinical trial. It describes a single person’s experience of feeling “too suppressed” — low appetite that makes it hard to fuel exercise. That kind of effect is known for semaglutide: many people report reduced hunger, and some struggle to eat enough, especially around exercise. But one person’s report can’t tell us how common this is or whether every-other-day dosing would work. Clinical studies test specific doses and schedules; changing the schedule can change blood levels of the drug and hasn’t been proven safe or effective unless a doctor recommends it. Why this matters: if you use Wegovy (or semaglutide) and you’re physically active, feeling overly suppressed can hurt performance, recovery, and overall energy. People who exercise a lot need to take in calories and protein at certain times, so persistent nausea or lack of appetite can be a real problem. If appetite suppression is interfering with daily life or workouts, it’s worth talking to your prescribing clinician about options — adjusting dose, timing, meal strategies, or switching formulations — rather than experimenting on your own. Important caveats: you should not change the prescribed dosing schedule without medical advice. Semaglutide levels in the body follow the approved regimen; skipping days can lead to unpredictable effects, withdrawal of benefit, or side effects. Common side effects include nausea, upset stomach, and low appetite; less common but serious risks (reported with this drug class) include pancreatitis and, in animal studies, rare thyroid tumors — discuss these with your provider. If you’re underweight, pregnant, trying to become pregnant, or have certain medical conditions, semaglutide may not be appropriate. Bottom line: feeling over-suppressed on Wegovy is a known issue and worth addressing, but don’t self-adjust to every-other-day dosing — talk to your clinician about safe ways to manage appetite, dosing, or alternative strategies.

Source: r/Semaglutide

Read full story

Back to Riding the pepTIDE